Ignite Creation Date:
2024-05-06 @ 7:34 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06057558
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-08
First Post:
2023-05-09
Brief Title:
Airway Microbiome of Cystic Fibrosis Patients
Sponsor:
University Hospital Antwerp
Organization:
University Hospital Antwerp
Study Overview
Official Title:
Studying the Airway Microbiome of Cystic Fibrosis Patients and the Potential of Probiotics for the Airways
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
With this study the investigators first want to investigate the respiratory tract microbiome of cystic fibrosis patients To achieve this the investigators will collect longitudinal samples of saliva throat and sputum and process these to determine the microbial composition and compare them over a timecourse of a year Secondly the investigators aim to study the influence of a topical microbiome therapy throat spray on the microbiome of the upper and lower respiratory tract in cystic fibrosis patients after administration for 6 weeks Bacterial and cytokine profiles of salivary throat and sputum samples will be monitored before during and after intervention
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None